F-star Therapeutics, Inc.

FSTX · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$31,283-$25,619-$23,013-$22,854
Dep. & Amort.$642$1,144$844$288
Deferred Tax-$104$345$4,247-$180
Stock-Based Comp.$6,898$3,489$2,669$2,776
Change in WC-$4,920$1,027-$8,505$180
Other Non-Cash$1,500$3,388$1,647-$5,454
Operating Cash Flow-$27,267-$16,226-$22,111-$25,244
Investing Activities
PP&E Inv.-$658-$730-$127-$1,972
Net Acquisitions$0$0$5,499$0
Inv. Purchases$0$0-$15,000-$58,000
Inv. Sales/Matur.$0$5,000$38,770$34,869
Other Inv. Act.$15$9,779-$23,770$0
Investing Cash Flow-$643$14,049$5,372-$25,103
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$78,346$15,000$6$37,960
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$88,099$15,850$13,264$41,172
Financing Cash Flow$88,099$15,850$13,264$41,172
Forex Effect-$166-$48$180$0
Net Chg. in Cash$60,023$13,625-$3,295-$9,175
Supplemental Information
Beg. Cash$18,526$4,901$8,196$24,133
End Cash$78,549$18,526$4,901$14,958
Free Cash Flow-$27,925-$16,956-$22,238-$27,216
F-star Therapeutics, Inc. (FSTX) Financial Statements & Key Stats | AlphaPilot